A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Published Date: 15 May 2024

Scientists at Johns Hopkins Medicine have discovered that up to 4.5 percent of papillary nevi may be explained by particular variations in three genes linked to maintaining the length of telomeres, the protective DNA endcaps on chromosomes.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

novel approach to test the toxicity of cancer drugs.

2.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

3.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

4.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

5.

New First-Line Option for Advanced ALK-Positive Lung Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot